Abstract
The first cyclic peptide discovered in animals is an antimicrobial octadecapeptide that is expressed in leukocytes of rhesus monkeys. The peptide, termed rhesus θdefensin 1 (RTD-1) is the prototype of a new family of antimicrobial peptides, which like the previously characterized α and βdefensin families, possesses broad spectrum microbicidal activities against bacteria, fungi, and protects mononuclear cells from infection by HIV-1. The cyclic θdefensin structure is essential for a number of its antimicrobial properties, as demonstrated by the markedly reduced microbicidal activities of de-cyclized θdefensin analogs. Genetic and biochemical experiments disclosed that the biosynthesis of RTD-1 results from the head-to-tail joining of two nine-amino acid peptides, each of which is donated by a separate precursor polypeptide, which are in fact C-terminally truncated pro-αdefensins. Alternate combinations of the two nonapeptides generate two additional macaque θdefensins, RTD-2 and RTD-3. Humans do not express θdefensin peptides, but mRNAs encoding at least two θdefensins are expressed in human bone marrow. However, in each case the open reading frame is interrupted by a stop codon in the signal peptide-coding region. The mature θdefensin peptide is a two-stranded βsheet that, like the α and βdefensins, is stabilized by three disulfides. However, the parallel orientation of the θ defensin disulfide arrangement allows for substantial flexibility around its short axis. Unlike α- and βdefensins, RTD-1 lacks an amphiphilic topology. This may partially explain the unusual interaction between θdefensins and phospholipid bilayers.
Keywords: theta-defensins, macrocyclic, cyclic peptides, antimicrobial
Current Protein & Peptide Science
Title: θ-Defensins: Cyclic Antimicrobial Peptides Produced by Binary Ligation of Truncated α-Defensins
Volume: 5 Issue: 5
Author(s): Michael E. Selsted
Affiliation:
Keywords: theta-defensins, macrocyclic, cyclic peptides, antimicrobial
Abstract: The first cyclic peptide discovered in animals is an antimicrobial octadecapeptide that is expressed in leukocytes of rhesus monkeys. The peptide, termed rhesus θdefensin 1 (RTD-1) is the prototype of a new family of antimicrobial peptides, which like the previously characterized α and βdefensin families, possesses broad spectrum microbicidal activities against bacteria, fungi, and protects mononuclear cells from infection by HIV-1. The cyclic θdefensin structure is essential for a number of its antimicrobial properties, as demonstrated by the markedly reduced microbicidal activities of de-cyclized θdefensin analogs. Genetic and biochemical experiments disclosed that the biosynthesis of RTD-1 results from the head-to-tail joining of two nine-amino acid peptides, each of which is donated by a separate precursor polypeptide, which are in fact C-terminally truncated pro-αdefensins. Alternate combinations of the two nonapeptides generate two additional macaque θdefensins, RTD-2 and RTD-3. Humans do not express θdefensin peptides, but mRNAs encoding at least two θdefensins are expressed in human bone marrow. However, in each case the open reading frame is interrupted by a stop codon in the signal peptide-coding region. The mature θdefensin peptide is a two-stranded βsheet that, like the α and βdefensins, is stabilized by three disulfides. However, the parallel orientation of the θ defensin disulfide arrangement allows for substantial flexibility around its short axis. Unlike α- and βdefensins, RTD-1 lacks an amphiphilic topology. This may partially explain the unusual interaction between θdefensins and phospholipid bilayers.
Export Options
About this article
Cite this article as:
Selsted E. Michael, θ-Defensins: Cyclic Antimicrobial Peptides Produced by Binary Ligation of Truncated α-Defensins, Current Protein & Peptide Science 2004; 5 (5) . https://dx.doi.org/10.2174/1389203043379459
DOI https://dx.doi.org/10.2174/1389203043379459 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Biomarkers in Diagnostics and Therapeutics: Advancements in Proteins and Peptides Across Preclinical and Clinical Studies
Biomarkers play a crucial role in the understanding and management of diseases, enabling clinicians and researchers to diagnose conditions earlier, predict disease outcomes, and develop personalized treatment strategies. Proteins and peptides, as key molecular entities, hold substantial promise in revolutionizing biomarker discovery, especially in the context of complex diseases such ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antibodies as Crypts of Antiinfective and Antitumor Peptides
Current Medicinal Chemistry Relative Hypermetabolism of Vermis Cerebelli in Traumatic Brain Injured Patients Studied with 18FDG PET: A Descriptor of Brain Damage and a Possible Predictor of Outcome
Current Radiopharmaceuticals Cholinesterase Inhibitors and Beyond
Current Alzheimer Research Involvement of the Blood-Brain Barrier in Metabolic Regulation
CNS & Neurological Disorders - Drug Targets Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology
Current Neuropharmacology Peptides as Carrier for Tumor Diagnosis and Treatment
Current Medicinal Chemistry - Anti-Cancer Agents MicroRNAs for Diagnosis and Treatment of Colorectal Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Preferential Codons Enhancing the Expression Level of Human Beta-Defensin-2 in Recombinant Escherichia Coli
Protein & Peptide Letters Ligand-Peroxidase Conjugates for Quantification of Receptor-Mediated Transport into Cells
Combinatorial Chemistry & High Throughput Screening Molecular Pathways Associated with Aggressiveness of Papillary Thyroid Cancer
Current Genomics Sam68 Promotes the Progression of Human Breast Cancer through inducing Activation of EphA3
Current Cancer Drug Targets Glucagon-Like Peptide 1 and the Cardiovascular System
Current Diabetes Reviews Aspartame Induce Modification in Membrane Bound and Antioxidant Enzymes in Liver and Kidney of Wistar Albino Rats
Current Nutrition & Food Science Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience
Current Pharmaceutical Design The Role of Fibroblast Growth Factor 21 (FGF21) on Energy Balance, Glucose and Lipid Metabolism
Current Diabetes Reviews Potential Telomere-Related Pharmacological Targets
Current Topics in Medicinal Chemistry A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
Current Cancer Drug Targets Mammary Development and Breast Cancer: The Role of Stem Cells
Current Molecular Medicine Prolactin and Blood-Brain Barrier Permeability
Current Neurovascular Research